- Home
- RDHL vs NUWE Comparison
RDHL vs NUWE Comparison
Compare RDHL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDHL | NUWE |
|---|---|---|
| Founded | 2009 | 1999 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 3.2M |
| IPO Year | 2012 | 2012 |
Fundamental Metrics
Financial Performance| Metric | RDHL | NUWE |
|---|---|---|
| Price | $0.55 | $0.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 3.0M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,270,000.00 |
| Revenue This Year | $381.91 | $11.14 |
| Revenue Next Year | N/A | $18.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $0.08 |
| 52 Week High | $2.79 | $6.40 |
Technical Indicators
Market Signals| Indicator | RDHL | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 43.23 |
| Support Level | N/A | $0.71 |
| Resistance Level | $0.76 | $1.20 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 2.07 | 18.82 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
About NUWE Nuwellis Inc.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.